Heart Failure Reviews
Overview
Heart Failure Reviews is a comprehensive and authoritative journal that focuses on the latest advancements in heart failure research and clinical practice. It provides in-depth reviews, original articles, and expert opinions on various aspects of heart failure, including pathophysiology, diagnosis, treatment, and management strategies. This journal serves as a valuable resource for healthcare professionals, researchers, and students interested in staying updated with the rapidly evolving field of heart failure.
Details
Details
Abbr.
Heart Fail Rev
Start
1996
End
Continuing
Frequency
Quarterly
p-ISSN
1382-4147
e-ISSN
1573-7322
Country
United States
Language
English
Metrics
Metrics
h-index / Ranks: 3170
99
SJR / Ranks: 2796
1208
CiteScore / Ranks: 1834
8.90
JIF / Ranks: 1820
4.6
Recent Articles
11.
Monzo L, Musella F, Girerd N, Rossignol P
Heart Fail Rev
. 2025 Jan;
PMID: 39883259
Mineralocorticoid receptor antagonists (MRAs) are a cornerstone of guideline-directed medical therapy for heart failure with reduced ejection fraction (HFrEF), offering significant benefits in reducing mortality and hospitalizations. However, their use...
12.
Koppe-Schmeisser F, Fengler K, Kresoja K, Lurz P, Rommel K
Heart Fail Rev
. 2025 Jan;
PMID: 39875629
Renal Denervation (RDN) has emerged over the last decade as a third pillar in the treatment of arterial hypertension, alongside pharmacotherapy and lifestyle modifications. Mechanistically, it reduces central sympathetic overactivation,...
13.
De Lorenzo L, Baratto C, Sala D, Perego G, Caravita S
Heart Fail Rev
. 2025 Jan;
PMID: 39863751
Left atrial (LA) hypertension is central in the pathophysiology of heart failure (HF) in general and of HF with preserved ejection fraction (HFpEF) in particular. Despite approved treatments, a number...
14.
Clarkson S, Lund L, Mebazaa A
Heart Fail Rev
. 2025 Jan;
PMID: 39849282
Heart failure (HF), a chronic and progressive disease, is increasing in prevalence worldwide and is associated with increased hospitalizations and death. Despite notable improvements in medical therapy for HF, patients...
15.
Kittipibul V, Lam C
Heart Fail Rev
. 2025 Jan;
PMID: 39849281
Heart failure with preserved ejection fraction (HFpEF) and atrial fibrillation (AF) are increasingly prevalent cardiovascular conditions, particularly among the elderly population. These two conditions share common risk factors and often...
16.
Shooshtarian A, OGallagher K, Shah A, Zhang M
Heart Fail Rev
. 2025 Jan;
PMID: 39843817
With rising incidence, mortality and limited therapeutic options, heart failure with preserved ejection fraction (HFpEF) remains one of the most important topics in cardiovascular medicine today. Characterised by left ventricular...
17.
Shahid I, Khan M, Butler J, Fonarow G, Greene S
Heart Fail Rev
. 2025 Jan;
PMID: 39815071
Strong evidence supports the importance of rapid sequence or simultaneous initiation of quadruple guideline-directed medical therapy (GDMT) for heart failure with reduced ejection fraction (HFrEF) for substantially reducing risk of...
18.
Sideris K, Kyriakopoulos C, Brinker L, Taleb I, Liori S, Hutman-Zahler A, et al.
Heart Fail Rev
. 2025 Jan;
PMID: 39808367
Right heart catheterization (RHC) provides critical hemodynamic insights by measuring atrial, ventricular, and pulmonary artery pressures, as well as cardiac output (CO). Although the use of RHC has decreased, its...
19.
Velollari O, Rommel K, Kresoja K, Lurz P, Gori T
Heart Fail Rev
. 2025 Jan;
PMID: 39804445
Heart failure is a prevalent global health issue. Heart failure with preserved ejection fraction (HFpEF), which already represents half of all heart cases worldwide, is projected to further increase, driven...
20.